iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-κB-dependent blockade

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 699-709

  Amarilyo, Gil ^a   Verbovetski, Inna ^a   Atallah, Mizhir ^a   Grau, Amir ^a   Wiser, Giora ^a   Gil, Oranit ^a   Ben Neriah, Ynon ^a   Mevorach, Dror ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Complement; iC3b; NF B

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT RECEPTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; ZYMOSAN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; THYMOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; COMPLEMENT C3B; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MICE; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; PHAGOCYTOSIS;

EID: 77749260603     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838951     Document Type: Article

References (55)

1. Savill, J. and Fadok, V., Corpse clearance defines the meaning of cell death. Nature 2000. 407: 784-788.
2. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998. 101: 890-898.
3. Freire-de-Lima, C. G., Xiao, Y. Q., Gardai, S. J., Bratton, D. L., Schiemann, W. P. and Henson, P. M., Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J. Biol. Chem. 2006. 281: 38376-38384.
4. Huynh, M. L., Fadok, V. A. and Henson, P. M., Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 2002. 109: 41-50.
5. Krispin, A., Bledi, Y., Atallah, M., Trahtemberg, U., Verbovetski, I., Nahari, E., Zelig, O. et al., Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood 2006. 108: 3580-3589.
6. Stuart, L. M., Lucas, M., Simpson, C., Lamb, J., Savill, J. and Lacy-Hulbert, A., Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 2002. 168: 1627-1635.
7. Tassiulas, I., Park-Min, K. H., Hu, Y., Kellerman, L., Mevorach, D. and Ivashkiv, L. B., Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum. Immunol. 2007. 68: 156-164.
8. Verbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I. et al., Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 2002. 196: 1553-1561.
9. Serhan, C. N. and Savill, J., Resolution of inflammation: the beginning programs the end. Nat. Immunol. 2005. 6: 1191-1197.
10. Scaffidi, P., Misteli, T. and Bianchi, M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002. 418: 191-195.
11. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M. et al., Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998. 19: 56-59.
12. Mevorach, D., Mascarenhas, J. O., Gershov, D. and Elkon, K. B., Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 1998. 188: 2313-2320.
13. Morelli, A. E., Larregina, A. T., Shufesky, W. J., Zahorchak, A. F., Logar, A. J., Papworth, G. D., Wang, Z. et al., Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003. 101: 611-620.
14. Gaipl, U. S., Kuenkele, S., Voll, R. E., Beyer, T. D., Kolowos, W., Heyder, P., Kalden, J. R. and Herrmann, M., Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ. 2001. 8: 327-334.
15. Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M. and Mevorach, D., Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J. Immunol. 2001. 167: 5963-5969.
16. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M. and Aderem, A., The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999. 401: 811-815.
17. Le Cabec, V., Carreno, S., Moisand, A., Bordier, C. and Maridonneau-Parini, I., Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J. Immunol. 2002. 169: 2003-2009.
18. Brown, G. D., Taylor, P. R., Reid, D. M., Willment, J. A., Williams, D. L., Martinez-Pomares, L., Wong, S. Y. and Gordon, S., Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 2002. 196: 407-412.
19. Speert, D. P. and Silverstein, S. C., Phagocytosis of unopsonized zymosan by human monocyte-derived macrophages: maturation and inhibition by mannan. J. Leukoc. Biol. 1985. 38: 655-658.
20. Giaimis, J., Lombard, Y., Fonteneau, P., Muller, C. D., Levy, R., Makaya-Kumba, M., Lazdins, J. and Poindron, P., Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. J. Leukoc. Biol. 1993. 54: 564-571.
21. Moynagh, P. N., TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005. 26: 469-476.
22. Gross, O., Gewies, A., Finger, K., Schafer, M., Sparwasser, T., Peschel, C., Forster, I. and Ruland, J., Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006. 442: 651-656.
23. Fujisawa, K., Aono, H., Hasunuma, T., Yamamoto, K., Mita, S. and Nishioka, K., Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 1996. 39: 197-203.
24. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N. et al., Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 1993. 13: 6231-6240.
25. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben-Neriah, Y., Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitinproteasome pathway. Proc. Natl. Acad. Sci. USA 1995. 92: 10599-10603.
26. Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., Mercurio, F. et al., Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. EMBO J. 1997. 16: 6486-6494.
27. Larson, R. S. and Springer, T. A., Structure and function of leukocyte integrins. Immunol. Rev. 1990. 114: 181-217.
28. Plow, E. F. and Zhang, L., A MAC-1 attack: integrin functions directly challenged in knockout mice. J. Clin. Invest. 1997. 99: 1145-1146.
29. Forsyth, C. B., Plow, E. F. and Zhang, L., Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 1998. 161: 6198-6205.
30. Cywes, C., Hoppe, H. C., Daffe, M. and Ehlers, M. R., Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect. Immun. 1997. 65: 4258-4266.
31. Matsuno, R., Aramaki, Y., Arima, H., Adachi, Y., Ohno, N., Yadomae, T. and Tsuchiya, S., Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochem. Biophys. Res. Commun. 1998. 244: 115-119.
32. Zarewych, D. M., Kindzelskii, A. L., Todd, R. F., III and Petty, H. R., LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J. Immunol. 1996. 156: 430-433.
33. Wright, S. D., Levin, S. M., Jong, M. T., Chad, Z. and Kabbash, L. G., CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 1989. 169: 175-183.
34. Diamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L. and Springer, T. A., The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 1993. 120: 1031-1043.
35. Ross, G. D., Cain, J. A. and Lachmann, P. J., Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 1985. 134: 3307-3315.
36. Henson, P. M., Bratton, D. L. and Fadok, V. A., Apoptotic cell removal. Curr. Biol. 2001. 11: R795-R805.
37. Lucas, M., Stuart, L. M., Zhang, A., Hodivala-Dilke, K., Febbraio, M., Silverstein, R., Savill, J. and Lacy-Hulbert, A., Requirements for apoptotic cell contact in regulation of macrophage responses. J. Immunol. 2006. 177: 4047-4054.
38. van Lookeren Campagne, M.,Wiesmann, C. and Brown, E. J., Macrophage complement receptors and pathogen clearance. Cell. Microbiol. 2007. 9: 2095-2102.
39. Obeid, M., Panaretakis, T., Tesniere, A., Joza, N., Tufi, R., Apetoh, L., Ghiringhelli, F. et al., Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Res. 2007. 67: 7941-7944.
40. Cvetanovic, M., Mitchell, J. E., Patel, V., Avner, B. S., Su, Y., van der Saag, P. T., Witte, P. L. et al., Specific recognition of apoptotic cells reveals a ubiquitous and unconventional innate immunity. J. Biol. Chem. 2006. 281: 20055-20067.
41. Vetvicka, V., Thornton, B. P. and Ross, G. D., Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 1996. 98: 50-61.
42. Cuzzola,M., Mancuso, G., Beninati, C., Biondo, C., Genovese, F., Tomasello, F., Flo, T. H. et al., Beta 2 integrins are involved in cytokine responses to whole Gram-positive bacteria. J. Immunol. 2000. 164: 5871-5876.
43. Medvedev, A. E., Flo, T., Ingalls, R. R., Golenbock, D. T., Teti, G., Vogel, S. N. and Espevik, T., Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 1998. 160: 4535-4542.
44. Aderem, A. A., Wright, S. D., Silverstein, S. C. and Cohn, Z. A., Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J. Exp. Med. 1985. 161: 617-622.
45. Wright, S. D. and Silverstein, S. C., Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 1983. 158: 2016-2023.
46. Yamamoto, K. and Johnston, R. B., Jr., Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J. Exp. Med. 1984. 159: 405-416.
47. Askew, D., Burger, C. J. and Elgert, K. D., Modulation of alloreactivity by Mac-1+, -2+, and -3+macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Immunobiology 1990. 182: 1-10.
48. Brandhorst, T. T., Wuthrich, M., Finkel-Jimenez, B., Warner, T. and Klein, B. S., Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection. J. Immunol. 2004. 173: 7444-7453.
49. Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R. and Sacks, D. L., Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 1996. 183: 515-526.
50. Karp, C. L., Wysocka, M., Wahl, L. M., Ahearn, J. M., Cuomo, P. J., Sherry, B., Trinchieri, G. and Griffin, D. E., Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996. 273: 228-231.
51. Marth, T. and Kelsall, B. L., Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 1997. 185: 1987-1995.
52. Sutterwala, F. S., Noel, G. J., Clynes, R. and Mosser, D. M., Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 1997. 185: 1977-1985.
53. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. and Henson, P. M., A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000. 405: 85-90.
54. Hom, G., Graham, R. R., Modrek, B., Taylor, K. E., Ortmann, W., Garnier, S., Lee, A. T. et al., Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 2008. 358: 900-909.
55. Witte, T., Dumoulin, F. L., Gessner, J. E., Schubert, J., Gotze, O., Neumann, C., Todd, R. F., III et al., Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus. J. Clin. Invest. 1993. 92: